The historical rank and industry rank for Mochida Pharmaceutical Co's Pretax Margin % or its related term are showing as below:
FRA:MFY'
s Pretax Margin % Range Over the Past 10 Years
Min: 5.99 Med: 10.09 Max: 13.24
Current: 9.55
FRA:MFY's Pretax Margin % is ranked better than 57.23% of 954
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs FRA:MFY: 9.55
Mochida Pharmaceutical Co (FRA:MFY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Mochida Pharmaceutical Co Pretax Margin % Related Terms
Mochida Pharmaceutical Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mochida Pharmaceutical Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Mochida Pharmaceutical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mochida Pharmaceutical Co (FRA:MFY) has a Pretax Margin % of 9.58% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Mochida Pharmaceutical Co and its competitors. This is near median its historical median of 10.09. Over the past decade, Mochida Pharmaceutical Co's Pretax Margin % has ranged from 5.99 to 13.24. According to the industry distribution chart, Mochida Pharmaceutical Co ranks #408 out of 954 companies in the Drug Manufacturers industry, placing it in the top 42.8%.
Is Mochida Pharmaceutical Co's Pretax Margin % too high?
Mochida Pharmaceutical Co's current Pretax Margin % of 9.58% is near median its 10-year median of 10.09. Over the past 10 years, this metric has ranged from a low of 5.99 to a high of 13.24. The Drug Manufacturers industry median Pretax Margin % is 7.30. Mochida Pharmaceutical Co's value of 9.58% is 31.3% above this industry median. Based on the distribution chart, Mochida Pharmaceutical Co ranks #408 out of 954 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Mochida Pharmaceutical Co has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mochida Pharmaceutical Co ranks #408 out of 954 companies for Pretax Margin %. This puts Mochida Pharmaceutical Co in the upper half of its industry. The industry median Pretax Margin % is 7.30. Mochida Pharmaceutical Co's value of 9.58% is 31.3% above this benchmark. Historically, Mochida Pharmaceutical Co's own Pretax Margin % has ranged from 5.99 to 13.24 over the past decade. While the company's 10-year median is 10.09 vs. the industry median of 7.30, Mochida Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mochida Pharmaceutical Co's current Pretax Margin % of 9.58% is 31.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Mochida Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mochida Pharmaceutical Co's current Pretax Margin % is 9.58%, which is near median its own 10-year median of 10.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (FRA:MFY) has a current Pretax Margin % of 9.58%. The stock's GF Value™ is €19.43, compared to a current price of €16.70 — trading 14.1% below its estimated fair value. The current Pretax Margin % is 9.58%, which is near median its 10-year median of 10.09 and 31.3% above the Drug Manufacturers industry median of 7.30. Mochida Pharmaceutical Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Mochida Pharmaceutical Co (FRA:MFY), the current Pretax Margin % is 9.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mochida Pharmaceutical Co (FRA:MFY) Overvalued in 2026?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued.
The current stock price of €16.70 is trading 14.1% below its estimated GF Value™ of €19.43.
Key valuation signals for FRA:MFY:
Pretax Margin %: 9.58% (near median its 10-year median of 10.09)
GF Value™: €19.43 vs. price of €16.70 (14.1% below fair value)
Industry Position: 31.3% above the Drug Manufacturers median (#408 of 954)
No single metric tells the full story. See the FRA:MFY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
72GF Score
Get the complete analysis for FRA:MFY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MFY has been successfully added to your 
